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INTRODUCTION  
 A 2,41 kg term female infant, born at 37 weeks gestation, 
was hospitalized four hours after birth with tachypnea and 
cyanosis.  
 She was a first child without any prenatal or familiar relevant 
diseases.  
 X-ray revealed bilateral reticulonodular infiltrates (Fig.1) and 











 She underwent several courses of exogenous surfactant 
and mechanical ventilation during the time she was 
hospitalized. 
 A lung biopsy was performed because congenital alveolar 
proteinosis was suspected.  
 The infant died three months after birth. 
 There were fibrosis in the alveolar septum and hemorrhagic 
infiltration in the alveolar luminae. 
 
 Alveolar macrophages number was greater than normal and 




















 No extensive inflammatory reaction was observed. 
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 Genetic surfactant dysfunction disorders are caused by 
mutations in genes encoding proteins critical for the 
production and function of pulmonary surfactant.  
 Pulmonary surfactant lowers alveolar surface tension and  
prevents alveolar collapse at the end of expiration. It is 
synthesized by alveolar type-II cells, stored in lamellar bodies 
and secreted by exocytosis1.  
 Surfactant is a complex mixture of 90% lipids (mostly 
phospholipids) and 10% surfactant-specific proteins (SP)-A,   
-B,-C and -D2.  
 Mutations in the genes encoding SP-B, SP-C and ATP-        
-binding cassette transporter 3 (ABCA3) have been 
associated with surfactant dysfunction and respiratory 
disease in full-term infants with neonatal respiratory failure 
and interstitial lung disease in older children and adults3. 
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DISCUSSION   
 Our final diagnosis was chronic pneumonitis of infancy 
(CPI). 
 CPI is caused, among others, by surfactant protein 
deficiency.  
 On routine histopathology the reported findings may 
suggest one of the surfactant disorders but it´s impossible to 
distinguish among the different genetic causes4. 
 Peripheral blood was sent for genetic study and no 
mutations were detected in the genes for SP-B and SP-C. 
ABCA3 gene analysis revealed a previously undescribed 
mutation: a compound heterozygote carrier of a leucine798 
(CTT)→proline (CCT)/p.Leu798Prol/L798P exchange and 
arginine1612 (CGG)→proline (CCG)/p.Arg1612Pro/R1612P 
substitution encoded by exons 18 and 31 of the ABCA3 gene. 
Both parents were tested for the mutation and they are 
heterozygotes.  
 ABCA3 gene deficiency was first described in 2004 and  
more than 150 disease-associated mutations have been 
described5.  
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